<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>16159543</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Fortún, Jesús</dc:author>
<dc:author>Rábago, Gregorio</dc:author>
<dc:author>Lumbreras, Carlos</dc:author>
<dc:author>Muñoz, Patricia</dc:author>
<dc:author>Gavaldá, Joan</dc:author>
<dc:author>Gil-Vernet, Salvador</dc:author>
<dc:author>Bernardos, Angel</dc:author>
<dc:author>Román, Antoni</dc:author>
<dc:author>de la Cámara, Rafael</dc:author>
<dc:author>Pérez, José Luis</dc:author>
<dc:author>Torre-Cisneros, Julián</dc:author>
<dc:author>Cisneros, José Miguel</dc:author>
<dc:author>Gurguí, Mercé</dc:author>
<dc:author>Pahissa, Albert</dc:author>
<dc:author>Varó, Evaristo</dc:author>
<dc:author>Martín, Carmen</dc:author>
<dc:author>Moreno, Asunción</dc:author>
<dc:author>Montejo, Miguel</dc:author>
<dc:author>Rovira, Montserrat</dc:author>
<dc:author>Aguado, José María</dc:author>
<dc:author>Martín-Dávila, Pilar</dc:author>
<dc:author>Quijano, Yolanda</dc:author>
<dc:description xml:lang="en">Cytomegalovirus (CMV) infection remains an important complication of transplantation. The last decade has been characterized by improvements to management that has reduced its morbidity and mortality. The advance has been particularly important in the diagnosis and prevention. Several techniques have been developed that allow the increasingly rapid and sensitive diagnosis. The different preventive strategies include use of appropriate blood products, immune globulin, and antiviral agents either as prophylaxis or pre-emptive therapy. The development of effective oral drugs as valganciclovir also represents a new advance. It is necessary to summarize these advances to facilitate the development of local policies reflecting recent changes. The Group of Study of Infections in Transplantation (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) has therefore produced actual recommendations in the management of CMV infection after transplantation.</dc:description>
<dc:type>Consensus Development Conference</dc:type>
<dc:language>es</dc:language>
<dc:date>2005 Aug-Sep </dc:date>
<dc:title xml:lang="es">Recomendaciones GESITRA-SEIMC y RESITRA sobre prevención y tratamiento de la infección por citomegalovirus en pacientes trasplantados.</dc:title>
<dc:title xml:lang="en">[Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients].</dc:title>
<dc:publisher>Enfermedades infecciosas y microbiologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
